Nitrilotriacetic Acid

Nitrilotriacetic Acid

SCHEMBL43736

O=C([O-])CN(CC(=O)[O-])CC(=O)[O-].O=C([O-])CN(CC(=O)[O-])CC(=O)[O-].[Ni+2].[Ni+2].[Ni+2]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
ALOX15 P16050 2/20 0.52
MAPT P10636 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CA4 P22748 3/20 0.41
CASP1 P29466 1/20 0.37
FFAR3 O14843 2/20 0.33
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
EYA2 O00167 1/20 0.33
APP P05067 1/20 0.33
ACE P12821 1/20 0.33
LMNA P02545 1/20 0.32
CHRM2 P08172 1/20 0.32
ADRA2A P08913 1/20 0.32
TSHR P16473 1/20 0.32
DRD1 P21728 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitrilotriacetic Acid SCHEMBL17982556 0.97 KDM4E (0.50) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL7458702 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL10664583 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL11309540 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL1684921 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL23358712 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL3482707 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL10890157 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL1284701 0.93 KDM4E (0.59) KDM4EALOX15MAPTSMN1; SMN2CA4
Nitrilotriacetic Acid SCHEMBL11684108 0.93 KDM4E (0.52) KDM4EALOX15MAPTSMN1; SMN2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6276 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024577-A1 INCORPORATING UNNATURAL AMINO ACIDS USING ONE POT PURE SYSTEM BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-01-30 WO claimed
US-12073966-B2 Droplet assembly method OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2024-08-27 US claimed
US-20240263205-A1 METHOD AND SYSTEM FOR PRODUCTION OF ADENOSINE TRIPHOSPHATE CORNELL RES FOUNDATION INC (US) 2024-08-08 US claimed
WO-2024143430-A1 SENSOR HAVING VESICLE TEMPLATE 株式会社TearExo 2024-07-04 WO claimed
WO-2024143431-A1 SENSOR COMBINED WITH PARTICLES 株式会社TearExo 2024-07-04 WO claimed
US-20240132819-A1 CELL NICHE ENGINEERING PLATFORM, MULTIPLEXED BIOCHIPS RESULTING THEREFROM AND METHODS OF USE THEREOF THE UNIVERSITY OF HONG KONG (CN) 2024-04-25 US claimed
WO-2024048837-A1 APPARATUS AND METHOD FOR CONTINUOUSLY PREPARING FORMIC ACID BY USING IMMOBILIZED CARBON DIOXIDE REDUCTASE 울산과학기술원 2024-03-07 WO claimed
WO-2024044276-A1 BALLISTIC MICROSCOPY (BAM): HIGH-THROUGHPUT CYTOPLASM SPATIO-TEMPORAL PICO-SAMPLING FROM LIVE-SINGLE CELLS FOR OMIC STUDIES USING PARTICLE BOMBARDMENT THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2024-02-29 WO claimed
CN-117295853-A Cell niche engineering platform, multiplexing biochip produced thereby and method of use thereof 香港大学 2023-12-26 CN claimed
EP-4288592-A1 CELL NICHE ENGINEERING PLATFORM, MULTIPLEXED BIOCHIPS RESULTING THEREFROM AND METHODS OF USE THEREOF The University of Hong Kong (CN) 2023-12-13 EP claimed
EP-1507002-A2 Thermostable Taq polymerase fragment Roche Diagnostics GmbH (DE) 2005-02-16 EP claimed
US-20040265392-A1 Nanoparticles comprising biologically active tnf which is immobilized on the same FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2004-12-30 US claimed
US-20040229330-A1 Integrated method for capture and purification of tagged proteins BAYER PHARMACEUTICALS CORPORATION 2004-11-18 US claimed
US-6723510-B2 ISOLATION OF MOLECULES OF INTEREST USING AFFINITY PARTICLES WHERE AT LEAST ONE STEP IN THE ISOLATION IS DONE IN THE PRESENCE OF A DETERGENT WHICH REDUCES LOSS OF PARTICLES AND ENHANCES YIELD OF THE MOLECULE OF INTEREST QIAGEN GMBH (DE) 2004-04-20 US claimed
US-6716433-B1 RECOMBINANT FUSION POLYPEPTIDE HAVING MULTIVALENT IMMUNOGENIC PORTION INCLUDING AT LEAST TWO AMINO-TERMINAL POLYPEPTIDES OF GROUP A STREPTOCOCCAL M PROTEIN FROM AT LEAST TWO DIFFERENT SEROTYPES, FUSED TO POLYPEPTIDE WHICH PROTECTS IMMUNOGENICITY UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2004-04-06 US claimed
US-20030078373-A1 CHAPERONE FRAGMENTS MEDICAL RESEARCH COUNCIL (GB) 2003-04-24 US claimed
US-5849545-A Substrate material for simultaneously binding genotypic and phenotypic substances EVOTEC BIOSYSTEMS GMBH (DE) 1998-12-15 US claimed
WO-1998024909-A1 CHAPERONE FRAGMENTS MEDICAL RESEARCH COUNCIL (GB) 1998-06-11 WO claimed
US-5643757-A High yield production of human apolipoprotein A1 in E. coli. AMERICAN CYANAMID COMPANY (US) 1997-07-01 US claimed
EP-0667960-B1 SUPPPORT MATERIAL FOR SIMULTANEOUS BINDING OF NUCLEIC ACIDS AND EXPRESSIONPRODUCTS THEREOF EVOTEC BIOSYSTEMS GMBH (DE) 1997-04-02 EP claimed